Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
暂无分享，去创建一个
Ming‐Lung Yu | Kuan-Yu Chen | S. Chuang | M. Yeh | Chung‐Feng Huang | Ching-I. Huang | C. Dai | Po-Cheng Liang | M. Hsieh | Zu-Yau Lin | Jee-Fu Huang | W. Chuang | Y. Tsai | Shinn-Cherng Chen | M. Hsieh | Nai‐Jen Hou | Yi-Hung Lin | Chih-Wen Wang | Tyng-Yuan Jang | Cheng-Ting Hsu | Po-Yao Hsu | Yu-Min Ko | Ching-Chih Lin | Yu-Ju Wei | Tzu-Sheng Cheng | Wen-Tsan Chang | Kuan-Yu Chen | M. Yu | Yi‐Hung Lin | Ching-I Huang | Jee‐Fu Huang | Chung-Feng Huang | Ming‐Yen Hsieh